Trial
NCT00876915
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Rochester
Collaborators
National Heart, Lung, and Blood Institute (NHLBI); Eisai Inc.
Condition
Venous Thromboembolism
Intervention
dalteparin injection
Why stopped
slow enrollment and lack of continuing funds
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-11-24